Advisor Group’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Advisor Group’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50	Closed	-$1K	–	5608
2019 Q3	$1K	Hold	50	–	–	﹤0.01%	5230
2019 Q2	$1K	Hold	50	–	–	﹤0.01%	5191
2019 Q1	$0	Hold	50	–	–	﹤0.01%	5426
2018 Q4	$0	Hold	50	–	–	﹤0.01%	5352
2018 Q3	$1K	Hold	50	–	–	﹤0.01%	5050
2018 Q2	$1K	Hold	50	–	–	﹤0.01%	4875
2018 Q1	$1K	Sell	50 -50	-50%	-$1.5K	﹤0.01%	4898
2017 Q4	$3K	Buy	+100	New	+$2.74K	﹤0.01%	4635

Advisor Group's DOVA Position: Q4 2019 in Review

Advisor Group sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 50 shares — an estimated $1K sold.

Advisor Group first reported a position in DOVA in Q4 2017 and held it in 8 quarters. The position peaked at $3K in Q4 2017. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Advisor Group reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Advisor Group sold 50 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1K.
Advisor Group first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Advisor Group's Dova Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q4 2017.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.